Rockefeller Capital Management
QNTM

Rockefeller Capital Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Rockefeller Capital Management’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145 Hold
30
– – ﹤0.01% 4620
2025
Q4 		$219 Hold
30
– – ﹤0.01% 4584
2025
Q3 		$492 Buy
+30
New +$592 ﹤0.01% 4270
2023
Q1 		– Sell
-62
Closed -$3K – 3952
2022
Q4 		$3K Hold
62
– – ﹤0.01% 3503
2022
Q3 		$3K Hold
62
– – ﹤0.01% 3524
2022
Q2 		$3K Hold
62
– – ﹤0.01% 3712
2022
Q1 		$3K Hold
62
– – ﹤0.01% 3538
2021
Q4 		$4K Buy
+62
New +$5.38K ﹤0.01% 3385

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Rockefeller Capital Management's QNTM Position: Q1 2026 in Review

Rockefeller Capital Management held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q1 2026 at 30 shares worth $145. The position accounts for ﹤0.01% of the portfolio, ranked #4620.

Rockefeller Capital Management first reported a position in QNTM in Q4 2021 and has held it in 8 quarters since. The position peaked at $4K in Q4 2021. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • Rockefeller Capital Management held 30 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $145 as of Q1 2026.
  • Rockefeller Capital Management left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q1 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4620 holding.
  • Rockefeller Capital Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2021 and has held it in 8 quarters since.
  • Rockefeller Capital Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $4K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.